Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
08/28/2003 | WO2003070725A2 Process for preparing indolinone derivatives |
08/28/2003 | WO2003070724A1 Substituted 4-pyrazolyl pyrazolines used for pest control |
08/28/2003 | WO2003070710A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
08/28/2003 | WO2003070709A1 Novel phenylalanine derivative |
08/28/2003 | WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
08/28/2003 | WO2003070277A1 Antipruritics |
08/28/2003 | WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
08/28/2003 | WO2003070230A1 Use of agents that modulate pde11a activity |
08/28/2003 | WO2003037384A3 Polymer conjugates of protein kinase c inhibitors |
08/28/2003 | WO2003028641A3 Mch receptor antagonists |
08/28/2003 | WO2002102359A3 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity |
08/28/2003 | US20030162965 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds |
08/28/2003 | US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
08/28/2003 | US20030162960 Compounds containing pyrroles as the key recognition element and a quinoxaline backbone as part of the compound for use in system with a built-in optical probe for selective sensing |
08/28/2003 | US20030162867 Stabilizer mixtures |
08/28/2003 | US20030162808 Acetindine derivatives, their preparation and medicaments containing them |
08/28/2003 | US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders |
08/28/2003 | US20030162797 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
08/28/2003 | US20030162794 Benzazole derivatives and their use as jnk modulators |
08/28/2003 | US20030162790 Benzimidazoles that are useful in treating sexual dysfunction |
08/28/2003 | US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
08/28/2003 | US20030162785 1,3-dihydro-2H-indol- 2-one derivatives |
08/28/2003 | US20030162784 Pyridazinone aldose reductase inhibitors |
08/28/2003 | US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
08/28/2003 | US20030162775 Heterocyclic substituted pyrazolones |
08/28/2003 | US20030162768 Treatment of Alzheimer's disease |
08/28/2003 | US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them |
08/28/2003 | US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
08/28/2003 | US20030162661 Selective control of harmful plants in crops of useful plants |
08/28/2003 | CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
08/28/2003 | CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
08/28/2003 | CA2475455A1 Process for preparing indolinone derivatives |
08/28/2003 | CA2419685A1 Antidiabetic agents |
08/27/2003 | EP1338592A1 Novel 2-phenylpiperazine derivatives |
08/27/2003 | EP1337531A2 Herbicidal heterocycles |
08/27/2003 | EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
08/27/2003 | EP1337520A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers |
08/27/2003 | EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
08/27/2003 | EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
08/27/2003 | EP1165547B1 Substituted benzoylpyrazoles as herbicides |
08/27/2003 | EP1095039B1 New pharmaceutically active compounds |
08/27/2003 | EP0862552B1 Succinimide and maleimide cytokine inhibitors |
08/27/2003 | CN1439007A 2-(3,5-disubstituted-4-pyridyl)-4(thienyl, thiazolylor arylphenyl)-1, 3-oxazoline compounds |
08/27/2003 | CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity |
08/27/2003 | CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors |
08/27/2003 | CN1438999A Serine protease inhibitors |
08/27/2003 | CN1438890A 腺苷受体调制剂 Adenosine receptor modulators |
08/27/2003 | CN1119346C Benzothiadiaxoles and derivatives |
08/27/2003 | CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
08/27/2003 | CN1119337C Substituted 2,4-diamino-1,3,5-triazine as herbicide |
08/27/2003 | CN1119329C Method of purifying carbazole ester precursors of 6-chloro-alpha-methy-carbazole-2-acetic acid |
08/27/2003 | CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists |
08/27/2003 | CN1119148C Use of alpha 1L agonists in treatment of in continence |
08/26/2003 | US6610882 Affinity for bradykinin receptors; antithrombotics |
08/26/2003 | US6610731 Antiinflammatory |
08/26/2003 | US6610730 Viricides; protease inbhibitor |
08/26/2003 | US6610723 Imidazole derivatives |
08/26/2003 | US6610719 Use of prostaglandin (PGE2) receptor a (EP4) selective agonists for the treatment of acute and chronic renal failure |
08/26/2003 | US6610695 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease |
08/26/2003 | US6610692 Anticoagulants |
08/26/2003 | US6610691 Carboxylic acid derivatives, their production and use |
08/26/2003 | US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia |
08/26/2003 | US6610641 Transition metal complex |
08/26/2003 | US6610631 Substituted aryl ketones |
08/26/2003 | US6610518 Using Cytochrome p450 |
08/22/2003 | CA2418930A1 Use of agents that modulate pde11a activity |
08/21/2003 | WO2003068768A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
08/21/2003 | WO2003068767A1 Pyrimidines as novel openers of potassium ion channels |
08/21/2003 | WO2003068757A1 Novel pyridin- and pyrimidin-derivatives |
08/21/2003 | WO2003068754A1 Therapeutic substituted indazole derivatives |
08/21/2003 | WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents |
08/21/2003 | WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders |
08/21/2003 | WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor |
08/21/2003 | WO2003068738A1 Pyrrole derivatives as ligands of melanocortin receptors |
08/21/2003 | WO2003068221A1 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
08/21/2003 | WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders |
08/21/2003 | WO2003068142A2 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents |
08/21/2003 | WO2003024935A3 Substituted pyrazolyl compounds for the treatment of inflammation |
08/21/2003 | WO2003020217A3 Novel pyrazole analogs acting on cannabinoid receptors |
08/21/2003 | WO2002094844A3 Antiviral nucleosides |
08/21/2003 | WO2002062755A3 Polyamide analogs as dna minor groove binders |
08/21/2003 | WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase |
08/21/2003 | WO2002036162A3 Compositions for treatment of ocular neovascularization and neural injury |
08/21/2003 | US20030158418 Novel imidazonline compounds |
08/21/2003 | US20030158405 N-benzhydryl indole compounds |
08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
08/21/2003 | US20030158248 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide |
08/21/2003 | US20030158244 Methods of treatment using a gastric retained losartan dosage |
08/21/2003 | US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis, |
08/21/2003 | US20030158225 Novel compounds |
08/21/2003 | US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents |
08/21/2003 | US20030158222 2-3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (an-tipsychotic agents) |
08/21/2003 | US20030158221 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome. |
08/21/2003 | US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders |
08/21/2003 | US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
08/21/2003 | US20030158205 N-benzyl-substituted, e.g., (2S)-1-(p-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(p -fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
08/21/2003 | US20030158182 Cyanopyrroles |
08/21/2003 | US20030158179 Quinoline derivatives |
08/21/2003 | US20030158177 Treating or preventing obesity |
08/21/2003 | US20030158173 NK 1 antagonists |